首页 | 本学科首页   官方微博 | 高级检索  
     

抗T淋巴细胞单克隆抗体治疗骨髓增生异常综合征
引用本文:王鲁群,迟翠芳,孔凡盛,黄宁,刘希民,李嵋,张东红,周兰月,张明珙,宋素芹. 抗T淋巴细胞单克隆抗体治疗骨髓增生异常综合征[J]. 中国肿瘤生物治疗杂志, 1996, 3(2): 124-126
作者姓名:王鲁群  迟翠芳  孔凡盛  黄宁  刘希民  李嵋  张东红  周兰月  张明珙  宋素芹
作者单位:济南军区总医院血液科!济南250031,济南军区总医院血液科!济南250031,济南军区总医院血液科!济南250031,济南军区总医院血液科!济南250031,济南军区总医院血液科!济南250031,济南军区总医院血液科!济南250031,济南军区总医院血液科!济南250031,济南军区总医院血液科!济南250031
摘    要:用抗T淋巴细胞单克隆抗体SMU3(抗CD3)和SMU8(抗CD8)治疗10例骨髓增生异常综合征(MDS),结果表明:2例明显进步,5例进步,白细胞和血红蛋白显著升高。治疗前CD4~ 细胞少,CD8~ 细胞多,CD4/CD8比值降低或倒置,HLA-DR抗原高表达,与对照组比较均有显著差异,治疗后T淋巴细胞亚群比例恢复,HLA-DR表达降低。T淋巴细胞各亚群比例失调和功能异常是MDS的诱发因素之一。

关 键 词:单克隆抗体  T淋巴细胞  骨髓增生异常综合征
收稿时间:1995-12-14
修稿时间:1996-03-04

Treatment of Myelodysplastic Syndrome with Monoclonal Anti-Human T Lymphocyte Antibody
Wang Luqun,Chi Cuifang,Kong Fansheng,Huang Ning,Liu Ximin,Li Mei,Zhang Donghong,Zhou Yuelan,Zhang Minghong and Song Suqin. Treatment of Myelodysplastic Syndrome with Monoclonal Anti-Human T Lymphocyte Antibody[J]. Chinses Journal of Cancer Biotherapy, 1996, 3(2): 124-126
Authors:Wang Luqun  Chi Cuifang  Kong Fansheng  Huang Ning  Liu Ximin  Li Mei  Zhang Donghong  Zhou Yuelan  Zhang Minghong  Song Suqin
Affiliation:Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031;Department of Hematology, Jinan General Hospital of PLA Jinan 250031
Abstract:Ten patients with myelodysplastic syndrome (MDS) were treated with monoclonal anti -human T lymphocyte antibodies SMU3 (anti - CD3) and SMU8 (anti - CD8) . The results suggested that two patients got a significant progress and five patients turned better. Before treatment the patients had less CD4 cells, more CD8 cells, lower or inverted ratio of CD4/ CD8, higher expression of HLA -DR antigen than normal control and these differences were significant. After treatment T lymphocyte subsets and HLA - DR expression turned normal. T lymphocyte subsets imbalance and abnormal function in patients is one of the factors which induced MDS.
Keywords:monoclonal antibody  T lymphocyte  myelodysplastic syndrome
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号